Why Canadian investors are stuck in their own Groundhog Day
In the 1993 movie Groundhog Day, the main character, Phil Connors, played by Bill Murray, is doomed to repeat February 2 over and over again until…
- April 4, 2016 September 13, 2019
- 09:27
In the 1993 movie Groundhog Day, the main character, Phil Connors, played by Bill Murray, is doomed to repeat February 2 over and over again until…
Making decisions with incomplete information can be a fact of life for anyone – personally or professionally. That being said, the degree of information that plan sponsors,…
Alberta is not the same place it was just 18 months ago when West Texas Intermediate crude oil was trading around US$100 per barrel. That’s…
New pension asset transfer rules governing single-employer pension plans (SEPPs) came into effect in Ontario on Jan. 1, 2014. The Ontario government recently released a…
Everybody worries. Did I do enough research before buying that house/car/laptop? Did I leave early enough to make it to work on time? Will the…
The financial risk to employers that provide prescription drug benefits for their employees has increased significantly over the past decade. Few employers have been lucky enough…
In recent years, pension plan sponsors were optimistic about upcoming de-risking activity. In a Towers Watson (now Willis Towers Watson) survey conducted in the summer…
Retirement planning has two equal sides, one in which the focus is saving for retirement (accumulation) and the other in which your focus is managing…
Plan sponsors need to prepare - and know their obligations to members.
The New Year is often greeted with enthusiasm and optimism. Not so 2016, which appears to be more of the same – volatile equity markets,…
If you are an [administrative services only (ASO)] plan sponsor, 2015 probably looked something like this with respect to your drug plan experience: Flat or…
The start of a New Year brings with it new beginnings and new possibilities. As a result, many of us choose to make resolutions to…
Stop-loss pools are under continued pressure to accommodate the ever-increasing number of claims for high-cost drugs. The explosion of claims for drugs to treat the…